Home
News
Create
Screeners
Insights
Bandaram Pharma Packtech
27.
75
-0.38
(-1.35%)
Market Cap
₹49.92 Cr
PE Ratio
85.24
Industry
Healthcare Services
Buy
Sell
Company Performance:
1D
-1.35%
1M
+0.91%
6M
+0.98%
1Y
-31.94%
5Y
+21.55%
View Company Insights
Latest news about Bandaram Pharma Packtech
Bandaram Pharma Packtech Limited Submits Q4FY26 Compliance Certificate Under SEBI Regulations
9 days ago
Bandaram Pharma Packtech Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) to BSE Limited on 11.04.2026. The certificate, issued by RTA Cameo Corporate Services Limited, confirms proper processing of dematerialisation requests, certificate mutilation procedures, and timely register updates for the quarter ended 31.03.2026.
Bandaram Pharma Packtech Submits EGM Notice Under Regulation 30 for April 27
Apr 03, 2026
Bandaram Pharma Packtech Announces Q3FY26 Results Under Regulation 33 Compliance
Feb 13, 2026
Bandaram Pharma Packtech Limited Announces Board Changes with New Director Appointment and Resignation
Jan 30, 2026
Bandaram Pharma Packtech Reports Q2 FY26 Loss of Rs. 34.74 Lakhs Amid Revenue Decline
Nov 14, 2025
More news about Bandaram Pharma Packtech
07
Nov 25
Bandaram Pharma Packtech Promoters Acquire Additional Shares Through Preferential Allotment
Bandaram Pharma Packtech Limited announced a major share acquisition by its promoters. Prajitha Bandaram acquired 486,480 shares through preferential allotment on November 6, 2025. This increased the company's equity share capital from Rs. 12.00 crores to Rs. 17.97 crores. After the acquisition, the promoter group's holdings include Prajitha Bandaram (486,480 shares), Satyavathi Bandaram (1,880,000 shares), B Premsai Reddy (1,880,000 shares), and M. Seetharama Reddy (112,500 shares). The disclosure was filed under SEBI regulations for substantial acquisition of shares and takeovers.
05
Sept 25
Bandaram Pharma Packtech Reappoints Chairman, Sets AGM Date for September 2025
Bandaram Pharma Packtech's board has approved the reappointment of Mr. Deepak Reddy Bandaram as Chairman and Managing Director for three years, subject to shareholder approval. The company's AGM for FY 2024-25 is scheduled for September 29, 2025, via video conference. The board also approved the Directors' Report for FY 2024-25.
Bandaram Pharma Packtech
27.
75
-
0.
38
(-
1.
35
%)
1 Year Returns:
-31.94%
Industry Peers
Dr. Lal Path Labs
1,437.10
(+
1.
30
%)
Vijaya Diagnostic Centre
1,040.25
(+
1.
65
%)
Metropolis Healthcare
493.95
(+
3.
90
%)
Thyrocare Technologies
394.00
(+
0.
34
%)
Nephrocare Health Services
567.30
(-
1.
02
%)
Krsnaa Diagnostics
612.55
(-
1.
99
%)
Suraksha Diagnostic
282.11
(+
0.
36
%)
3B BlackBio DX
1,400.00
(+
7.
54
%)
One Global Service Provider
567.90
(-
4.
02
%)
Sastasundar Ventures
272.25
(+
0.
70
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO